Optimal gestational weight gain in women with pregestational type 2 diabetes: a population-based cohort study in China

The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines f...

Full description

Saved in:
Bibliographic Details
Published inDiabetology and metabolic syndrome Vol. 17; no. 1; pp. 339 - 11
Main Authors Xue, Yiwei, Cui, Zifeng, Shu, Xinyu, Juan, Juan, Kang, Xin, Yao, Mi, Chen, Xu, Wei, Zhuo, Kong, Lingyi, Chen, Haitian, Cui, Shihong, Gao, Fengchun, Zhu, Ping, Yan, Jianying, Xu, Xia, Zhang, Li, Wang, Yanxia, Mi, Yang, Yang, Huixia
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 18.08.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist. A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets. The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial. The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes.
AbstractList Abstract Background The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist. Methods A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets. Results The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0–12.5 kg, 5.0–11.0 kg, and 4.0–11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial. Conclusion The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes.
The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist. A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets. The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial. The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes.
The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist.BACKGROUNDThe global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist.A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets.METHODSA nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets.The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial.RESULTSThe results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial.The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes.CONCLUSIONThe current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes.
Background The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist. Methods A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets. Results The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial. Conclusion The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes. Keywords: Type 2 diabetes mellitus, Gestational weight gain, Adverse pregnancy outcomes
The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective weight management during pregnancy is critically associated with maternal and neonatal outcomes. However, no universally accepted guidelines for gestational weight gain (GWG) in high-risk pregnancies with T2DM currently exist. A nationwide, multicenter cohort of 2078 T2DM pregnancies was analyzed, categorizing GWG based on latest Chinese guidelines. Multivariate regression analyses were performed to evaluate the impact of GWG deviations on adverse pregnancy outcomes. Interquartile range (IQR) analysis and restricted cubic splines were used to determine BMI-specific GWG targets. The results showed that insufficient GWG was protective against cesarean delivery, large-for-gestational-age (LGA), and macrosomia but increased risks of preterm birth and congenital anomalies. Excessive GWG significantly elevated risks of preeclampsia, LGA, macrosomia, and neonatal hypoglycemia, while protecting against small-for-gestational-age (SGA). Using interquartile range method, we identified GWG ranges for normal-weight, overweight, and obese women were 7.0-12.5 kg, 5.0-11.0 kg, and 4.0-11.2 kg, respectively. Restricted cubic splines suggested relaxing the lower limit to 6 kg for normal BMI but showed risks below 1.8 kg. For overweight and obese women, GWG below guideline limits was beneficial. The current GWG guidelines may not fully suit T2DM pregnancies, particularly for overweight and obese women, highlighting the need for BMI-specific recommendations to optimize maternal and neonatal outcomes.
ArticleNumber 339
Audience Academic
Author Wang, Yanxia
Kong, Lingyi
Zhang, Li
Cui, Shihong
Gao, Fengchun
Chen, Xu
Zhu, Ping
Xue, Yiwei
Yan, Jianying
Cui, Zifeng
Kang, Xin
Yang, Huixia
Yao, Mi
Shu, Xinyu
Juan, Juan
Xu, Xia
Mi, Yang
Chen, Haitian
Wei, Zhuo
Author_xml – sequence: 1
  givenname: Yiwei
  surname: Xue
  fullname: Xue, Yiwei
– sequence: 2
  givenname: Zifeng
  surname: Cui
  fullname: Cui, Zifeng
– sequence: 3
  givenname: Xinyu
  surname: Shu
  fullname: Shu, Xinyu
– sequence: 4
  givenname: Juan
  surname: Juan
  fullname: Juan, Juan
– sequence: 5
  givenname: Xin
  surname: Kang
  fullname: Kang, Xin
– sequence: 6
  givenname: Mi
  surname: Yao
  fullname: Yao, Mi
– sequence: 7
  givenname: Xu
  surname: Chen
  fullname: Chen, Xu
– sequence: 8
  givenname: Zhuo
  surname: Wei
  fullname: Wei, Zhuo
– sequence: 9
  givenname: Lingyi
  surname: Kong
  fullname: Kong, Lingyi
– sequence: 10
  givenname: Haitian
  surname: Chen
  fullname: Chen, Haitian
– sequence: 11
  givenname: Shihong
  surname: Cui
  fullname: Cui, Shihong
– sequence: 12
  givenname: Fengchun
  surname: Gao
  fullname: Gao, Fengchun
– sequence: 13
  givenname: Ping
  surname: Zhu
  fullname: Zhu, Ping
– sequence: 14
  givenname: Jianying
  surname: Yan
  fullname: Yan, Jianying
– sequence: 15
  givenname: Xia
  surname: Xu
  fullname: Xu, Xia
– sequence: 16
  givenname: Li
  surname: Zhang
  fullname: Zhang, Li
– sequence: 17
  givenname: Yanxia
  surname: Wang
  fullname: Wang, Yanxia
– sequence: 18
  givenname: Yang
  surname: Mi
  fullname: Mi, Yang
– sequence: 19
  givenname: Huixia
  surname: Yang
  fullname: Yang, Huixia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40826373$$D View this record in MEDLINE/PubMed
BookMark eNptkstq3DAUhk1JaS7tC3RRDIXSjVNdLEvqJoShl0Agm3YtdDm2FTyWa8kZ5u2rmUnDDBQJSRx9-nWO9F8WZ2MYoSjeY3SNsWi-REyRFBUirEKYC1JtXhUXmDNRMSmbs6P1eXEZ4yNCDWe8flOc10iQhnJ6UTw9TMmv9VB2EJNOPox5vQHf9anstB_L3DdhDXn0qS-nGY7BtJ2gJKXz2kCC-LXU5RSmZdjvV0ZHcKUNfZhTGdPitju1Ve9H_bZ43eohwrvn-ar4_f3br9XP6v7hx93q9r6yNWWbSrZSttwa2yLdGmstNcjUjUEEa4yckJzVBlNArrWSNYJLTrllyGIgwtaEXhV3B10X9KOa5lzqvFVBe7UPhLlTek7eDqA4pwIT7ZwBqAETSSy2Lt9NcxLGuKx1c9CaFrMGZ2FMsx5ORE93Rt-rLjwpTCiTomFZ4fOzwhz-LPkd1dpHC8OgRwhLVJTUSGaayox-PKCdzrn5sQ1Z0u5wdSsYoVhQjjJ1_R8qNwdrb7NbWp_jJwc-HR3oQQ-pj2FYdv8VT8EPx8W-VPnPORkgB8DOIcYZ2hcEI7WzpzrYU2V7qr091Yb-BSsS2N0
Cites_doi 10.12114/j.issn.1007-9572.2024.0027
10.2337/dc22-S015
10.1007/s00125-012-2721-z
10.1001/jama.2017.3635
10.1056/NEJM199904223401603
10.1136/bmj.i555
10.1136/bmj-2022-072249
10.1055/s-0036-1585410
10.17226/12584
10.1038/s41440-022-00965-6
10.7326/0003-4819-122-7-199504010-00001
10.1001/jama.2019.3820
10.1093/pch/pxz134
10.1007/s00404-017-4573-8
10.1016/j.diabres.2022.109811
10.1038/nrendo.2016.37
10.31083/j.ceog5102034
10.1111/ppe.12741
10.1080/14767058.2017.1405388
10.1155/2018/1242901
10.1002/bdr2.2165
10.1038/s41430-022-01238-8
10.3389/fendo.2024.1348382
10.2471/blt.07.043497
10.1038/jp.2011.15
10.1186/s12916-018-1128-1
10.1016/j.ajog.2011.06.028
10.1001/jamanetworkopen.2022.33250
10.1186/s12884-022-04762-4
10.1136/bmjopen-2023-075226
10.1111/jog.15448
10.3760/cma.j.cn112141-20210917-00528
10.1111/obr.12521
10.1001/jamanetworkopen.2022.33256
10.1016/j.diabres.2023.110797
10.4236/aasoci.2017.76014
10.1007/s00429-021-02450-1
10.1038/s41572-019-0098-8
10.1016/S0140-6736(24)00255-1
10.1111/1471-0528.17461
10.1111/obr.12238
ContentType Journal Article
Copyright 2025. The Author(s).
COPYRIGHT 2025 BioMed Central Ltd.
The Author(s) 2025 2025
Copyright_xml – notice: 2025. The Author(s).
– notice: COPYRIGHT 2025 BioMed Central Ltd.
– notice: The Author(s) 2025 2025
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1186/s13098-025-01782-w
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic


PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1758-5996
EndPage 11
ExternalDocumentID oai_doaj_org_article_773812addbee4e1292c1cdcbc3f99bbd
PMC12359865
A852318370
40826373
10_1186_s13098_025_01782_w
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: the Youth Program of National Natural Science Foundation of China
  grantid: 82003528
– fundername: National Key Research and Development Program of China
  grantid: 2021YFC2700700
– fundername: the National High Level Hospital Clinical Research Funding
  grantid: 22cz020401-4811009
GroupedDBID ---
0R~
53G
5VS
7X7
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACPRK
ACUHS
ADBBV
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
E3Z
EBD
EBLON
EBS
ESX
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TUS
U2A
UKHRP
NPM
PUEGO
7X8
5PM
ID FETCH-LOGICAL-c435w-9f99f7cbcf0afbccc3b0b46b021a10d89754b13e0dfc956879737c50c1e28c423
IEDL.DBID DOA
ISSN 1758-5996
IngestDate Wed Aug 27 01:28:35 EDT 2025
Thu Aug 21 18:23:32 EDT 2025
Wed Aug 20 00:33:50 EDT 2025
Wed Aug 27 16:52:36 EDT 2025
Tue Aug 26 03:41:09 EDT 2025
Tue Aug 26 02:12:35 EDT 2025
Thu Aug 28 04:25:25 EDT 2025
Thu Aug 21 00:29:08 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Gestational weight gain
Adverse pregnancy outcomes
Type 2 diabetes mellitus
Language English
License 2025. The Author(s).
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c435w-9f99f7cbcf0afbccc3b0b46b021a10d89754b13e0dfc956879737c50c1e28c423
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://doaj.org/article/773812addbee4e1292c1cdcbc3f99bbd
PMID 40826373
PQID 3240912339
PQPubID 23479
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_773812addbee4e1292c1cdcbc3f99bbd
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12359865
proquest_miscellaneous_3240912339
gale_infotracmisc_A852318370
gale_infotracacademiconefile_A852318370
gale_healthsolutions_A852318370
pubmed_primary_40826373
crossref_primary_10_1186_s13098_025_01782_w
PublicationCentury 2000
PublicationDate 20250818
PublicationDateYYYYMMDD 2025-08-18
PublicationDate_xml – month: 8
  year: 2025
  text: 20250818
  day: 18
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Diabetology and metabolic syndrome
PublicationTitleAlternate Diabetol Metab Syndr
PublicationYear 2025
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Chinese Society of Perinatal Medicine, Chinese Medical Association, Commitee of Pregnancy with Diabetes Mellitus, China Maternal and Child Health Association (1782_CR22) 2022; 57
J Jia (1782_CR21) 2024; 27
Z Chu (1782_CR38) 2024; 51
AD Gernand (1782_CR40) 2016; 12
X Yan (1782_CR30) 2024; 15
MZ Kapadia (1782_CR44) 2015; 16
MR Narvey (1782_CR27) 2019; 24
DD McIntire (1782_CR43) 1999; 340
1782_CR4
1782_CR11
Z Cheng (1782_CR10) 2023; 77
SV Glinianaia (1782_CR2) 2012; 55
E Voerman (1782_CR15) 2019; 321
1782_CR19
Capital Institute of Pediatrics HL (1782_CR26) 2020; 58
B-F Zhou (1782_CR23) 2002; 15
Y Zhu (1782_CR3) 2024
MS Dos Santos (1782_CR31) 2023; 202
W Kosiek (1782_CR41) 2022; 227
X Fan (1782_CR14) 2023; 49
N Perumal (1782_CR37) 2023; 382
L Toxvig (1782_CR45) 2017; 7
F Chen (1782_CR8) 2022; 5
GA Colditz (1782_CR20) 1995; 122
M de Onis (1782_CR7) 2007; 85
J Fu (1782_CR35) 2022; 186
BA Situ (1782_CR39) 2023; 115
LM Yee (1782_CR12) 2011; 205
X Jiang (1782_CR9) 2019; 32
C Viecceli (1782_CR36) 2017; 18
A Bronisz (1782_CR42) 2018; 2018
1782_CR29
R-X Dai (1782_CR34) 2018; 297
HD McIntyre (1782_CR1) 2019; 5
HJ Teede (1782_CR5) 2022; 5
M Hong (1782_CR18) 2022; 22
B Pethő (1782_CR33) 2023; 130
KR Goetzinger (1782_CR32) 2017; 34
RF Goldstein (1782_CR6) 2018; 16
RF Goldstein (1782_CR16) 2017; 317
H Metoki (1782_CR25) 2022; 45
LM Bodnar (1782_CR28) 2020; 35
JG Ouzounian (1782_CR17) 2011; 31
LC Ismail (1782_CR24) 2016; 352
K Johansson (1782_CR13) 2024; 403
References_xml – volume: 27
  start-page: 3609
  year: 2024
  ident: 1782_CR21
  publication-title: Chin General Pract
  doi: 10.12114/j.issn.1007-9572.2024.0027
– ident: 1782_CR29
  doi: 10.2337/dc22-S015
– volume: 55
  start-page: 3193
  year: 2012
  ident: 1782_CR2
  publication-title: Diabetologia
  doi: 10.1007/s00125-012-2721-z
– volume: 317
  start-page: 2207
  year: 2017
  ident: 1782_CR16
  publication-title: JAMA
  doi: 10.1001/jama.2017.3635
– volume: 340
  start-page: 1234
  year: 1999
  ident: 1782_CR43
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199904223401603
– volume: 352
  year: 2016
  ident: 1782_CR24
  publication-title: BMJ
  doi: 10.1136/bmj.i555
– volume: 382
  year: 2023
  ident: 1782_CR37
  publication-title: BMJ
  doi: 10.1136/bmj-2022-072249
– volume: 34
  start-page: 217
  year: 2017
  ident: 1782_CR32
  publication-title: Am J Perinat
  doi: 10.1055/s-0036-1585410
– ident: 1782_CR4
  doi: 10.17226/12584
– volume: 45
  start-page: 1298
  year: 2022
  ident: 1782_CR25
  publication-title: Hypertens Res
  doi: 10.1038/s41440-022-00965-6
– volume: 122
  start-page: 481
  year: 1995
  ident: 1782_CR20
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-122-7-199504010-00001
– volume: 321
  start-page: 1702
  year: 2019
  ident: 1782_CR15
  publication-title: JAMA
  doi: 10.1001/jama.2019.3820
– volume: 24
  start-page: 536
  year: 2019
  ident: 1782_CR27
  publication-title: Paediatr Child Health
  doi: 10.1093/pch/pxz134
– volume: 297
  start-page: 139
  year: 2018
  ident: 1782_CR34
  publication-title: Arch Gynecol Obstet
  doi: 10.1007/s00404-017-4573-8
– volume: 186
  start-page: 109811
  year: 2022
  ident: 1782_CR35
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2022.109811
– volume: 12
  start-page: 274
  year: 2016
  ident: 1782_CR40
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2016.37
– volume: 51
  start-page: 34
  year: 2024
  ident: 1782_CR38
  publication-title: CEOG
  doi: 10.31083/j.ceog5102034
– volume: 35
  start-page: 459
  year: 2020
  ident: 1782_CR28
  publication-title: Paediatr Perinat Epidemiol
  doi: 10.1111/ppe.12741
– volume: 32
  start-page: 1353
  year: 2019
  ident: 1782_CR9
  publication-title: J Matern Fetal Neonatal Med
  doi: 10.1080/14767058.2017.1405388
– volume: 2018
  start-page: 1242901
  year: 2018
  ident: 1782_CR42
  publication-title: Int J Endocrinol
  doi: 10.1155/2018/1242901
– volume: 115
  start-page: 753
  year: 2023
  ident: 1782_CR39
  publication-title: Birth Defects Res
  doi: 10.1002/bdr2.2165
– volume: 77
  start-page: 356
  year: 2023
  ident: 1782_CR10
  publication-title: Eur J Clin Nutr
  doi: 10.1038/s41430-022-01238-8
– volume: 15
  start-page: 1348382
  year: 2024
  ident: 1782_CR30
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2024.1348382
– volume: 85
  start-page: 660
  year: 2007
  ident: 1782_CR7
  publication-title: Bull World Health Organ
  doi: 10.2471/blt.07.043497
– volume: 31
  start-page: 717
  year: 2011
  ident: 1782_CR17
  publication-title: J Perinatol
  doi: 10.1038/jp.2011.15
– volume: 16
  start-page: 153
  year: 2018
  ident: 1782_CR6
  publication-title: BMC Med
  doi: 10.1186/s12916-018-1128-1
– volume: 205
  start-page: e1
  issue: 257
  year: 2011
  ident: 1782_CR12
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2011.06.028
– volume: 5
  year: 2022
  ident: 1782_CR8
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2022.33250
– volume: 22
  start-page: 424
  year: 2022
  ident: 1782_CR18
  publication-title: Bmc Pregnancy Childb
  doi: 10.1186/s12884-022-04762-4
– year: 2024
  ident: 1782_CR3
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2023-075226
– volume: 49
  start-page: 182
  year: 2023
  ident: 1782_CR14
  publication-title: J Obstet Gynaecol Re
  doi: 10.1111/jog.15448
– volume: 57
  start-page: 3
  year: 2022
  ident: 1782_CR22
  publication-title: Chin J Obstet Gynecol
  doi: 10.3760/cma.j.cn112141-20210917-00528
– volume: 18
  start-page: 567
  year: 2017
  ident: 1782_CR36
  publication-title: Obes Rev
  doi: 10.1111/obr.12521
– volume: 5
  year: 2022
  ident: 1782_CR5
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2022.33256
– volume: 15
  start-page: 83
  year: 2002
  ident: 1782_CR23
  publication-title: Biomed Environ Sci
– volume: 202
  start-page: 110797
  year: 2023
  ident: 1782_CR31
  publication-title: Diabetes Res Clin Pr
  doi: 10.1016/j.diabres.2023.110797
– volume: 7
  start-page: 227
  year: 2017
  ident: 1782_CR45
  publication-title: Adv Appl Sociol
  doi: 10.4236/aasoci.2017.76014
– ident: 1782_CR11
– volume: 58
  start-page: 738
  issue: 9
  year: 2020
  ident: 1782_CR26
  publication-title: Chin J Pediatr.
– volume: 227
  start-page: 1099
  year: 2022
  ident: 1782_CR41
  publication-title: Brain Struct Funct
  doi: 10.1007/s00429-021-02450-1
– volume: 5
  start-page: 47
  year: 2019
  ident: 1782_CR1
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-019-0098-8
– volume: 403
  start-page: 1472
  year: 2024
  ident: 1782_CR13
  publication-title: The Lancet
  doi: 10.1016/S0140-6736(24)00255-1
– volume: 130
  start-page: 1217
  year: 2023
  ident: 1782_CR33
  publication-title: BJOG
  doi: 10.1111/1471-0528.17461
– ident: 1782_CR19
– volume: 16
  start-page: 189
  year: 2015
  ident: 1782_CR44
  publication-title: Obes Rev
  doi: 10.1111/obr.12238
SSID ssj0067574
Score 2.3626409
Snippet The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity. Effective...
Background The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and obesity....
Abstract Background The global prevalence of pregestational type 2 diabetes mellitus (T2DM) has increased concurrently with increasing rates of overweight and...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 339
SubjectTerms Adverse pregnancy outcomes
Analysis
Cesarean section
Genetic disorders
Gestational weight gain
Pregnant women
Type 2 diabetes
Type 2 diabetes mellitus
Title Optimal gestational weight gain in women with pregestational type 2 diabetes: a population-based cohort study in China
URI https://www.ncbi.nlm.nih.gov/pubmed/40826373
https://www.proquest.com/docview/3240912339
https://pubmed.ncbi.nlm.nih.gov/PMC12359865
https://doaj.org/article/773812addbee4e1292c1cdcbc3f99bbd
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_0BPFF_LZ6rhEEH6Rcm7RN4tud3HkId4p4sG8hmaZ6D_aWvT3333cm3S5bfPBFKH1ohtJkZjIfzfwG4K1sfG3aiLlU2FCAQqrodWnzqlNSBy1jgZzQPztvTi-qz_N6vtPqi8-EDfDAw8IdaE02RZIWhhirSNZJYoktBlSdtSG0vPuSzRuDqWEPJi9YV2OJjGkOrmmn5lIyyQfVyCbm64kZSmj9f-_JO0ZpemByxwKdPID7G9dRHA6f_BBuxf4R3D3b_Bx_DL-_kPr_Igr-ZbTJ8Yl1Sn2KH_6yF3QlwAXByVexWMZdQs7FCinGXOwH4cVi29wrZ2PXCu6mu1yJBEnLb0vNt5_Axcnx94-n-aatQo7kG61zSwvXaVrBrvBdQEQVilA1gay9L4vWWF1XoVSxaDvkYkJttdJYF1hGaZDcr6ew11_18TkIXzA6vuabr6xGjx3pN0oKfKPShc_g_bjKbjGgZ7gUdZjGDTxxxBOXeOLWGRwxI7aUjHydHpA8uI08uH_JQwavmY1uKCPd6q87NBRylwz1k8G7RMEaTNykjx4KEWhKjIU1odyfUJLm4WT4zSgqjof4uFofr26uHaMcWvIJlM3g2SA621lxh-9GaZWBmQjVZNrTkf7yZwL-5rpma5r6xf9YqJdwTyaFMHlp9mFvtbyJr8jBWoUZ3NZzPYM7R8fnX7_NkmbR_dO8_ANw8SlU
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimal+gestational+weight+gain+in+women+with+pregestational+type+2+diabetes%3A+a+population-based+cohort+study+in+China&rft.jtitle=Diabetology+and+metabolic+syndrome&rft.au=Xue%2C+Yiwei&rft.au=Cui%2C+Zifeng&rft.au=Shu%2C+Xinyu&rft.au=Juan%2C+Juan&rft.date=2025-08-18&rft.pub=BioMed+Central+Ltd&rft.issn=1758-5996&rft.eissn=1758-5996&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs13098-025-01782-w&rft.externalDocID=A852318370
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-5996&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-5996&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-5996&client=summon